Therapeutic efficacy and safety of Compound Kushen Injection combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An update systematic review and meta-analysis

Background: Compound Kushen Injection (CKI) is a Chinese patent medicine approved by the Chinese State Food and Drug Administration for the treatment of various types of solid tumors. CKI, combined with transarterial chemoembolization (TACE), is believed to increase the therapeutic efficacy of unres...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Xiao eMa, Ruisheng eLi, Jian eWang, Yinqiu eHuang, Pengyan eLi, Ji eWang, Haibin eSu, Ruilin eWang, Yaming eZhang, Honghong eLiu, Congen eZhang, Zhijie eMa, Jiabo eWang, Yanling eZhao, Xiaohe eXiao
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2016-03-01
Edice:Frontiers in Pharmacology
Témata:
Meta-analysis
Systematic review
Transarterial chemoembolization
Compound kushen injection
Unresectable hepatocellular carcinoma
On-line přístup:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00070/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky